Banaschewski, Tobias
Johnson, Mats
Nagy, Peter
Otero, Isabel Hernández
Soutullo, César A.
Yan, Brian
Zuddas, Alessandro
Coghill, David R.
Article History
First Online: 23 May 2018
Compliance with Ethical Standards
:
: This study was funded by Shire Development LLC. Writing and editing assistance for this paper was provided by Oxford PharmaGenesis, funded by Shire International GmbH. Shire International GmbH also funded open access.
: Brian Yan is an employee of Shire and owns stock or stock options. The following authors have received compensation for serving as consultants or speakers for, or they or the institutions they work for have received research support or royalties from, the companies or organisations indicated: Tobias Banaschewski (Actelion, CIP Medien, Hexal Pharma, Hogrefe, Kohlhammer, Lilly, Medice, Novartis, Otsuka, Oxford University Press, Shire, Vifor Pharma); David R. Coghill (Eli Lilly, Janssen-Cilag, Medice, Novartis, Oxford University Press, Shire, Vifor Pharma); Mats Johnson (Eli Lilly, Evolan, Ginsana, PCM Scientific, New Nordic, Shire, Vifor Pharma); Peter Nagy (Lilly, Otsuka, Medice, Shire); Isabel Hernández Otero (Alicia Koplowitz Foundation, Eli Lilly, Forest, Janssen-Cilag, Junta de Andalucía, Roche, Shire, Shire Pharmaceuticals Iberica S.L., Sunovion); César A. Soutullo (Alicia Koplowitz Foundation, Editorial Médica Panamericana, Eli Lilly, Fundación Caja Navarra, Lundbeck, Mayo Eds, Medice/Juste, NeuroTech Solutions, Rubiò, Shire); and Alessandro Zuddas (Angelini, EduPharma, Lilly, Lundbeck, Otsuka, Oxford University Press, Roche, Shire, Takeda, Vifor Pharma).
: This study was approved by the appropriate ethics committees and was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments, as well as other applicable local ethical and legal requirements.
: Written informed consent was obtained from all individual participants included in the study. Informed consent and assent, where applicable, was documented (on an appropriate form approved by the ethics committee) by the dated signature of the participant and the participant’s legally authorised representative/parents, as applicable.